Ultra-Sensitive, Fully Automated Simoa® Cytokine 4-Plex Advantage PLUS Assays
Three panels, 11 essential cytokine biomarkers, femtogram sensitivity
With Simoa® ultra-sensitive protein quantification, the cutting-edge Advantage PLUS assay platform, and full automation of the HD-X Analyzer, the Simoa® Cytokine 4-Plex Advantage PLUS Assays will transform cytokine biomarker analysis, delivering deeper insights and scalable results like never before.
Download the Cytokine 4-Plex Advantage PLUS Product Flyer to learn more
Related Posts
Building Custom High-Plex Biomarker Panels
Scale Your Spatial Discoveries with Molecular Barcoding
Spatial Analysis
PhenoCode Molecular Barcoding Kit
Introducing the Metabolism Spike-in Module for IO60
Neurology
NfL Fact Sheet
Neurofilament light (NfL) has emerged in recent years as a blood-based biomarker with the potential to aid in the improvement of early diagnosis and patient care of neuro-axonal injury and…
PhenoCode Discovery Immune Activation and Proliferation Human Protein Module
Neurology
Brain-Derived Tau (BD-Tau) Fact Sheet
Brain-derived Tau (BD-Tau) is one of the latest additions to the growing neurology biomarker family that holds promise to improve the accuracy in the identification and staging of neurodegeneration in…
Neurology
Simoa® Technology Powering Advancements in Neurology
Flyer Quanterix empowers researchers with cutting-edge Simoa® digital immunoassays that measure both established and emerging biomarkers in neurology. Simoa® technology sets the gold standard for early biomarker detection in serum,…